A Phase 3, Randomized Study of Nivolumab Plus Ipilimumab in Combination With Chemotherapy vs Chemotherapy Alone as First Line Therapy in Stage IV Non-Small Cell Lung Cancer
Phase of Trial: Phase III
Latest Information Update: 26 Dec 2018
At a glance
- Drugs Ipilimumab (Primary) ; Nivolumab (Primary) ; Carboplatin; Cisplatin; Paclitaxel; Pemetrexed
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Acronyms CheckMate 9LA
- Sponsors Bristol-Myers Squibb
- 19 Dec 2018 Planned number of patients changed from 700 to 840.
- 10 Sep 2018 Planned number of patients changed from 840 to 700.
- 31 Aug 2018 Biomarkers information updated